Avandia, a widely prescribed diabetes drug has been linked to a significantly higher risk of heart attacks and death from cardiovascular causes according to a research analysis of 42 studies published in The New England Journal of Medicine on May 21, 2007. The study prompted the FDA to issue a Safety Alert the same day.

Avandia, generically known as rosiglitazone, and made by GlaxoSmithKline, was found to be associated with a 43% increased risk of heart attack and a 64% increased risk of death from cardiac related causes. The results are based upon an analysis of 15,560 patients who took Avandia and a control group of 12,283 patients who received placebos or other drugs. Avandia was approved in 1999 for treatment of type 2 diabetes, which affects approximately 18 to 20 million Americans.

If you or a loved one has suffered a heart attack or cardiac-related death after taking Avandia or Avandamet, then you may be entitled to monetary compensation for your injuries and damages. If you would like to have an attorney contact you for a free confidential consultation, please fill out the form below.

If you would prefer to speak to someone directly, please contact us.